A. MENARINI ASIA-PACIFIC HOLDINGS

The Menarini Group is a leading Italian pharmaceutical company committed to delivering high-quality, innovative medicines and services globally. With a focus on research, collaboration, and internationalization, we strive to meet the needs of physicians and patients alike. Our commitment to quality is evident in our efficient systems and processes, which have created a unique standard for ensuring excellence throughout all phases of drug manufacturing. With a consolidated turnover of 3,750 billion euro in 2020 and a presence in 140 countries, we employ over 17,650 people across 10 R&D centers and 18 manufacturing sites. In 2020, we produced 581 million packs of product.

Menarini is the world's largest Italian biopharmaceutical company with a heritage of over 128 years, operating across 100+ countries globally. Our vision in Asia-Pacific is to be a leading provider of essential healthcare brands to enhance the lives of people in the region. We operate across the entire commercial value chain, from regulatory approval to lifecycle management, with a diverse portfolio of proprietary and partnered brands in key therapeutic areas such as Dermatology, Select Specialty Care, Allergy/Respiratory, Cardiovascular, Men's Health, and Consumer Health.